Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone
- PMID: 38004537
- PMCID: PMC10674291
- DOI: 10.3390/pharmaceutics15112558
Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone
Abstract
Loratadine (LRD), a non-sedating and slow-acting antihistamine, is often given in combination with short-onset chlorpheniramine maleate (CPM) to increase efficacy. However, LRD has poor water solubility resulting in low bioavailability. The aim of this study was to improve LRD solubility by preparing co-amorphous LRD-CPM. However, the obtained co-amorphous LRD-CPM recrystallized rapidly, and the solubility of LRD returned to a poor state again. Therefore, co-amorphous LRD-CPM solid dispersions using polyvinylpyrrolidone (PVP) as a carrier were prepared. The obtained solid dispersions were characterized using X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FT-IR). The solubility, dissolution, and mechanism of drug release from the LRD-CPM/PVP co-amorphous solid dispersions were studied and compared with those of intact LRD, LRD/PVP solid dispersions, and co-amorphous LRD-CPM mixtures. The results from XRPD and DSC confirmed the amorphous form of LRD in the co-amorphous solid dispersions. The FTIR results indicated that there was no intermolecular interaction between LRD, CPM, and PVP. In conclusion, the obtained LRD-CPM/PVP co-amorphous solid dispersions can successfully increase the water solubility and dissolution of LRD and extend the amorphous state of LRD without recrystallization.
Keywords: amorphous; chlorpheniramine; film casting; loratadine; polyvinylpyrrolidone; quench cooling; solid dispersion; solubility enhancement.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Loratadine oral bioavailability enhancement via solid dispersion loaded oro-dispersible films: Formulation, characterization and pharmacokinetics.Colloids Surf B Biointerfaces. 2023 Oct;230:113526. doi: 10.1016/j.colsurfb.2023.113526. Epub 2023 Aug 25. Colloids Surf B Biointerfaces. 2023. PMID: 37647750
-
Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.Pharm Dev Technol. 2007;12(1):21-33. doi: 10.1080/10837450601166510. Pharm Dev Technol. 2007. PMID: 17484141
-
Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:501-511. doi: 10.1016/j.msec.2016.11.042. Epub 2016 Nov 14. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 28024614
-
Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.J Pharm Sci. 2010 Mar;99(3):1322-35. doi: 10.1002/jps.21914. J Pharm Sci. 2010. PMID: 19798757
-
Advancing Drug Delivery Paradigms: Polyvinyl Pyrolidone (PVP)-Based Amorphous Solid Dispersion for Enhanced Physicochemical Properties and Therapeutic Efficacy.Polymers (Basel). 2024 Jan 20;16(2):286. doi: 10.3390/polym16020286. Polymers (Basel). 2024. PMID: 38276694 Free PMC article. Review.
Cited by
-
The influence of natural polymers on loratadine's solubility and dissolution profiles.J Med Life. 2024 Mar;17(3):305-308. doi: 10.25122/jml-2023-0529. J Med Life. 2024. PMID: 39044927 Free PMC article.
-
Design of Experiment Approach for Enhancing the Dissolution Profile and Robustness of Loratadine Tablet Using D-α-Tocopheryl Polyethylene Glycol 1000 Succinate.Pharmaceutics. 2025 Mar 17;17(3):380. doi: 10.3390/pharmaceutics17030380. Pharmaceutics. 2025. PMID: 40143043 Free PMC article.
-
Solid Dispersions Obtained by Ball Milling as Delivery Platform of Etodolac, a Model Poorly Soluble Drug.Materials (Basel). 2024 Aug 7;17(16):3923. doi: 10.3390/ma17163923. Materials (Basel). 2024. PMID: 39203102 Free PMC article.
References
-
- Benes M., Pekarek T., Beranek J., Havlicek J., Krejcik L., Simek M., Tkadlecova M., Dolezal P. Methods for the preparation of amorphous solid dispersions—A comparative study. J. Drug Deliv. Sci. Technol. 2017;38:125–134. doi: 10.1016/j.jddst.2017.02.005. - DOI
-
- Suknuntha K., Jones D.S., Tantishaiyakul V. Properties of felodipine-poly(vinylpyrrolidone) solid dispersion films and the impact of solvents. Sci. Asia. 2012;38:188–195. doi: 10.2306/scienceasia1513-1874.2012.38.188. - DOI
-
- Pandey M.M., Jaipal A., Charde S.Y., Goel P., Kumar L. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: Insight into the role of drug-polymer interactions on drug dissolution. Pharm. Dev. Technol. 2016;21:463–474. doi: 10.3109/10837450.2015.1022785. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources